Damme, Markus <br/><br/>
Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.  [electronic resource] 

 -  Journal of neuropathology and experimental neurology  Jan 2011 
 - 83-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-6578 
<br/><br/><label>Standard No.: </label>10.1097/NEN.0b013e31820428fa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CHO Cells<br/>Cerebellum--enzymology<br/>Cricetinae<br/>Cricetulus<br/>Disease Models, Animal<br/>Enzyme Replacement Therapy--methods<br/>Gene Targeting<br/>Humans<br/>Lameness, Animal--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Neurologic Mutants<br/>Treatment Outcome<br/>alpha-Mannosidase--deficiency<br/>alpha-Mannosidosis--drug therapy